1-9 of 9
Michael LeBlanc
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Reverse Selection Designs for Accommodating Multiple Control Arms

Available to Purchase
Sarah Samorodnitsky, Megan Othus, Michael LeBlanc, Michael C. Wu
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (24): 5535–5539.
https://doi.org/10.1158/1078-0432.CCR-24-1282
Published: 16 December 2024
View articletitled, Reverse Selection Designs for Accommodating Multiple Control Arms
Open the PDF for Reverse Selection Designs for Accommodating Multiple Control Arms in another window
Includes: Supplementary data
Journal Articles

Lung Master Protocol (Lung-MAP)—A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400

Available to Purchase
Roy S. Herbst, David R. Gandara, Fred R. Hirsch, Mary W. Redman, Michael LeBlanc, Philip C. Mack, Lawrence H. Schwartz, Everett Vokes, Suresh S. Ramalingam, Jeffrey D. Bradley, Dana Sparks, Yang Zhou, Crystal Miwa, Vincent A. Miller, Roman Yelensky, Yali Li, Jeff D. Allen, Ellen V. Sigal, David Wholley, Caroline C. Sigman, Gideon M. Blumenthal, Shakun Malik, Gary J. Kelloff, Jeffrey S. Abrams, Charles D. Blanke, Vassiliki A. Papadimitrakopoulou
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (7): 1514–1524.
https://doi.org/10.1158/1078-0432.CCR-13-3473
Published: 31 March 2015
View articletitled, Lung Master Protocol (Lung-MAP)—A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400
Open the PDF for Lung Master Protocol (Lung-MAP)—A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400 in another window
Journal Articles

Historical Controls for Metastatic Pancreatic Cancer: Benchmarks for Planning and Analyzing Single-Arm Phase II Trials

Free
Philip A. Philip, Kari Chansky, Michael LeBlanc, Lawrence Rubinstein, Lesley Seymour, S. Percy Ivy, Steven R. Alberts, Paul J. Catalano, John Crowley
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2014) 20 (16): 4176–4185.
https://doi.org/10.1158/1078-0432.CCR-13-2024
Published: 13 August 2014
View articletitled, Historical Controls for Metastatic Pancreatic Cancer: Benchmarks for Planning and Analyzing Single-Arm Phase II Trials
Open the PDF for Historical Controls for Metastatic Pancreatic Cancer: Benchmarks for Planning and Analyzing Single-Arm Phase II Trials in another window
Journal Articles

A Comparative Analysis of Prognostic Factor Models for Follicular Lymphoma Based on a Phase III Trial of CHOP–Rituximab versus CHOP + 131Iodine—Tositumomab

Available to Purchase
Oliver W. Press, Joseph M. Unger, Lisa M. Rimsza, Jonathan W. Friedberg, Michael LeBlanc, Myron S. Czuczman, Mark Kaminski, Rita M. Braziel, Catherine Spier, Ajay K. Gopal, David G. Maloney, Bruce D. Cheson, Shaker R. Dakhil, Thomas P. Miller, Richard I. Fisher
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (23): 6624–6632.
https://doi.org/10.1158/1078-0432.CCR-13-1120
Published: 01 December 2013
View articletitled, A Comparative Analysis of Prognostic Factor Models for Follicular Lymphoma Based on a Phase III Trial of CHOP–Rituximab versus CHOP + 131Iodine—Tositumomab
Open the PDF for A Comparative Analysis of Prognostic Factor Models for Follicular Lymphoma Based on a Phase III Trial of CHOP–Rituximab versus CHOP + 131Iodine—Tositumomab in another window
Includes: Supplementary data
Journal Articles

Modeling the Relationship between Progression-Free Survival and Overall Survival: The Phase II/III Trial

Available to Purchase
Mary W. Redman, Bryan H. Goldman, Michael LeBlanc, Anne Schott, Laurence H. Baker
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (10): 2646–2656.
https://doi.org/10.1158/1078-0432.CCR-12-2939
Published: 12 May 2013
View articletitled, Modeling the Relationship between Progression-Free Survival and Overall Survival: The Phase II/III Trial
Open the PDF for Modeling the Relationship between Progression-Free Survival and Overall Survival: The Phase II/III Trial in another window
Journal Articles

Choosing Phase II Endpoints and Designs: Evaluating the Possibilities

Available to Purchase
Michael LeBlanc, Catherine Tangen
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (8): 2130–2132.
https://doi.org/10.1158/1078-0432.CCR-12-0454
Published: 16 April 2012
View articletitled, Choosing Phase II Endpoints and Designs: Evaluating the Possibilities
Open the PDF for Choosing Phase II Endpoints and Designs: Evaluating the Possibilities in another window
Includes: Supplementary data
Journal Articles

Development and Use of Integral Assays in Clinical Trials

Available to Purchase
Richard L. Schilsky, James H. Doroshow, Michael LeBlanc, Barbara A. Conley
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (6): 1540–1546.
https://doi.org/10.1158/1078-0432.CCR-11-2202
Published: 14 March 2012
View articletitled, Development and Use of Integral Assays in Clinical Trials
Open the PDF for Development and Use of Integral Assays in Clinical Trials in another window
Journal Articles

Multiple Histology Phase II Trials

Available to Purchase
Michael LeBlanc, Cathryn Rankin, John Crowley
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (13): 4256–4262.
https://doi.org/10.1158/1078-0432.CCR-08-2069
Published: 01 July 2009
View articletitled, Multiple Histology Phase II Trials
Open the PDF for Multiple Histology Phase II Trials in another window
Journal Articles

Randomized Phase II Designs

Available to Purchase
Larry Rubinstein, John Crowley, Percy Ivy, Michael LeBlanc, Dan Sargent
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (6): 1883–1890.
https://doi.org/10.1158/1078-0432.CCR-08-2031
Published: 16 March 2009
View articletitled, Randomized Phase II Designs
Open the PDF for Randomized Phase II Designs in another window